Precigen and the RRPF recognise International RRP Awareness Day

Guardant Health expands FDA-approved companion diagnostic use for HERNEXEOS

GSK to acquire Nuvalent for USD10.6bn to expand lung cancer portfolio

Adcentrx Therapeutics' ADRX-0405 granted Chinese regulatory IND clearance to treat late-stage solid tumours

Evogene completes Phase 1 study of BMC128 in combination with Nivolumab

Cumberland Pharmaceuticals and Vanderbilt Health report data from Phase 2a trial of ifetroban to prevent cancer metastasis

Amgen receives EU marketing authorisation for IMDYLLTRA in ES-SCLC

Haisco receives US FDA approval for anaesthetic Cipepofol

hVIVO secures Decoy Therapeutics consultancy contract for antiviral development

Dizal presents positive NSCLC data for DZD6008 and golidocitinib at ASCO 2026

Enhertu recommended for EU approval in previously treated HER2 positive metastatic solid tumours

Nanjing Leads Biolabs receives Chinese approval for pivotal Phase III trial of PD-L1/4-1BB bispecific antibody

CelLBxHealth partners with AdventHealth on cancer monitoring studies

GSK's Arexvy gains expanded approval in Japan for at-risk adults aged 18-49

SN BioScience reports first patient dosed in global Phase 1b/2 clinical trial of SNB-101